Scan to download
BTC $76,813.55 -1.55%
ETH $2,290.37 -2.45%
BNB $623.36 -1.33%
XRP $1.39 -2.17%
SOL $84.51 -2.36%
TRX $0.3254 +0.42%
DOGE $0.0978 -0.98%
ADA $0.2455 -2.44%
BCH $448.62 -0.62%
LINK $9.23 -2.33%
HYPE $41.73 +0.76%
AAVE $97.02 +0.96%
SUI $0.9271 -1.65%
XLM $0.1647 -3.30%
ZEC $357.93 +0.81%
BTC $76,813.55 -1.55%
ETH $2,290.37 -2.45%
BNB $623.36 -1.33%
XRP $1.39 -2.17%
SOL $84.51 -2.36%
TRX $0.3254 +0.42%
DOGE $0.0978 -0.98%
ADA $0.2455 -2.44%
BCH $448.62 -0.62%
LINK $9.23 -2.33%
HYPE $41.73 +0.76%
AAVE $97.02 +0.96%
SUI $0.9271 -1.65%
XLM $0.1647 -3.30%
ZEC $357.93 +0.81%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01
Collection

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.